Key
- This grey face represents the number of people in the survey group.
- This green face represents the one person in the survey group that the medicine has helped.
Research studies have looked at how likely it is that Metoprolol will reduce risk of death due in people with mild to severe heart failure.
Research suggests:
In a group of 28 patients with mild to severe heart failure, Metoprolol will prevent one person from this group (on average) from dying over a period of one year.
This picture illustrates how likely it is that a person taking Metoprolol will get this benefit.
It is not possible to tell what will happen to you as an individual.
Find out more about this research at:
https://www.ncbi.nlm.nih.gov/pubmed/10376614
(Tooltip - Mean age of patients in this study was 64 years. Current treatment included a combination of ACE inhibitors, Angiotensin receptor blockers and diuretics. . Metoprolol dose was 200 mg/day)